Perdita Taylor-Zapata, M.D., is a board certified pediatrician from the Washington Metropolitan area. She graduated from Howard University Medical school in 1994, and completed her pediatric residency training at the Children's National Medical Center in Washington, D.C. After residency, she started working at the National Institutes of Health as a clinic physician in the Pediatric HIV Working Group of the National Cancer Institute (NCI). There she spent 7 years taking care of the outpatient and inpatient medical needs of the HIV-positive pediatric patients enrolled in phase I/II clinical treatment trials. In addition to her role as a staff physician, she was also involved in medical research writing parts of clinical protocols and conducting retrospective and prospective research projects. As her career developed during her stay at NCI, she became interested in the use, side effects, and toxicity profiles of medications used in children and published a paper in Pediatrics in 2004 on Lipodystrophy in HIV-infected Children. In August of 2004, Dr. Taylor-Zapata joined the Obstetric and Pediatric Pharmacology branch of the NICHD, where she is now a medical officer working with a team of experts responsible for the implementation of the Best Pharmaceuticals for Children Act (BPCA).